Home › Mologic Gets CE Mark for Infection Dx

Mologic Gets CE Mark for Infection Dx

Jun 14, 2017

NEW YORK (360Dx) – British diagnostics firm Mologic today said that it has received CE marking for its Periplex point-of-care test for detection of infections in patients undergoing peritoneal dialysis.

The company said that it also has launched the test.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

What's Popular?

In Infectious Disease

  1. Roche Patent Invalidation Affirmed in TB Testing Lawsuit Against Cepheid

  2. BD Obtains CE Mark for Molecular TB, MDR-TB Assay

  3. Antibiotic Resistance Monitoring Consortium Expands to Highlight Battle Against Superbugs

    Premium

  4. OpGen Posts Preliminary Q3 Revenue Decline of 36 Percent

  5. Dissatisfied With Lyme Disease Dx Methods, Researchers Emphasize Potential of New Technologies

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.